These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9924036)

  • 21. Patients with prostate cancer should be enrolled in a national, controlled trial.
    Willis RG
    BMJ; 1999 Jan; 318(7176):126. PubMed ID: 9880299
    [No Abstract]   [Full Text] [Related]  

  • 22. Young men with prostate cancer: are they different and how should they be managed?
    Khan MA
    BJU Int; 2007 May; 99(5):1169. PubMed ID: 17437448
    [No Abstract]   [Full Text] [Related]  

  • 23. Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions.
    Han LC; Delpe S; Shah ND; Ziegenfuss JY; Tilburt JC; Karnes RJ; Nguyen PL; Gross CP; Yu JB; Trinh QD; Sun M; Ranasinghe WK; Kim SP
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):277-83. PubMed ID: 24685153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initiation of salvage therapy for prostate cancer.
    Johnstone PA; Booth R; Riffenburgh RH; Amling CL; Kane CJ; Moul JW
    Prostate Cancer Prostatic Dis; 2002; 5(2):136-43. PubMed ID: 12497004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in prostate cancer presentation coinciding with USPSTF screening recommendations at a community-based urology practice.
    Gaylis FD; Choi JE; Hamilton Z; Dato P; Cohen E; Calabrese R; Prime H; Rosenbaum A; Kader AK
    Urol Oncol; 2017 Nov; 35(11):663.e1-663.e7. PubMed ID: 28736250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Decision aids for patients are widely accepted by German urologists : A survey among members of the German Society of Urology (DGU) and the Federation of German Urologists (BDU)].
    Groeben C; Baunacke M; Borkowetz A; Kliesch S; Wülfing C; Ihrig A; Huber J
    Urologe A; 2016 Jun; 55(6):784-91. PubMed ID: 26969330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Congress of the European Urology Association 2004: state and perspective of prostate cancer management].
    Rouprêt M; Beley S
    Ann Urol (Paris); 2004 Aug; 38 Suppl(1):S1-15. PubMed ID: 15495948
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
    Fu AZ; Tsai HT; Haque R; Ulcickas Yood M; Van Den Eeden SK; Cassidy-Bushrow AE; Zhou Y; Keating NL; Smith MR; Aaronson DS; Potosky AL
    World J Urol; 2016 Dec; 34(12):1611-1619. PubMed ID: 27084777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supervisor volume affects oncological outcomes of trainees performing open radical prostatectomy.
    O'Kane D; Papa N; Lawrentschuk N; Syme R; Giles G; Bolton D
    ANZ J Surg; 2016 Apr; 86(4):249-54. PubMed ID: 25916513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease.
    Arvold ND; Chen MH; Moul JW; Moran BJ; Dosoretz DE; Bañez LL; Katin MJ; Braccioforte MH; D'Amico AV
    J Urol; 2011 Jul; 186(1):91-6. PubMed ID: 21571341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer.
    Dalela D; Karabon P; Sammon J; Sood A; Löppenberg B; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 Apr; 71(4):511-514. PubMed ID: 27638094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer in the older man: conflict between tumor biology and medical advancement.
    Cummings JM
    Clin Geriatr Med; 2010 May; 26(2):241-7. PubMed ID: 20497843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Pathological Outcomes for Men with Low Risk Prostate Cancer from Diverse Practice Settings: Similar Results from Immediate Prostatectomy or Initial Surveillance with Delayed Prostatectomy.
    Auffenberg GB; Linsell S; Dhir A; Myers SN; Rosenberg B; Miller DC;
    J Urol; 2016 Nov; 196(5):1415-1421. PubMed ID: 27256204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy.
    Prasad SM; Keating NL; Wang Q; Pashos CL; Lipsitz S; Richie JP; Hu JC
    Urology; 2008 Sep; 72(3):647-52; discussion 652-3. PubMed ID: 18649928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials.
    Carducci MA; Carroll PR
    Urology; 2005 May; 65(5 Suppl):18-22; discussion 22. PubMed ID: 15885275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
    Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
    Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.